Eagle Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.2M	Buy	8,119 +1,440	+22%	+$692K	0.02%	405
2024 Q2	$3.15M	Buy	6,679 +814	+14%	+$353K	0.02%	434
2024 Q1	$2.47M	Sell	5,865 -243	-4%	-$103K	0.01%	460
2023 Q4	$2.49M	Sell	6,108 -977	-14%	-$361K	0.01%	435
2023 Q3	$2.46M	Sell	7,085 -280	-4%	-$97.9K	0.01%	418
2023 Q2	$2.59M	Buy	7,365 +643	+10%	+$217K	0.01%	423
2023 Q1	$2.12M	Buy	+6,722	New	+$2.02M	0.01%	435
2016 Q2	–	Sell	-98,933	Closed	-$7.86M	–	656
2016 Q1	$7.86M	Buy	98,933 +7,634	+8%	+$691K	0.05%	347
2015 Q4	$11.5M	Buy	91,299 +9,494	+12%	+$1.15M	0.08%	316
2015 Q3	$8.52M	Buy	81,805 +10,021	+14%	+$1.29M	0.06%	345
2015 Q2	$8.86M	Buy	71,784 +3,067	+4%	+$386K	0.05%	348
2015 Q1	$8.11M	Buy	68,717 +213	+0.3%	+$25.5K	0.05%	362
2014 Q4	$8.14M	Buy	68,504 +2,208	+3%	+$249K	0.05%	353
2014 Q3	$7.45M	Buy	+66,296	New	+$6.31M	0.04%	371
2013 Q4	–	Sell	-353,623	Closed	-$26.9M	–	662
2013 Q3	$26.9M	Buy	353,623 +408	+0.1%	+$32.5K	0.13%	202
2013 Q2	$28.3M	Buy	+353,215	New	+$26M	0.19%	171